Susquehanna International Group, LLP Neuro Bo Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$0.72 - $1.54 $42,984 - $91,938	-59,700 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.22 - $2.5 $42,456 - $87,000	-34,800 Reduced 36.83%	59,700 $73,000
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.52 $8,190 - $13,559	3,000 Added 3.28%	94,500 $352,000
Q2 2021 Aug 11, 2021	SELL	$2.74 - $4.63 $103,024 - $174,088	-37,600 Reduced 29.12%	91,500 $305,000
Q1 2021 May 17, 2021	BUY	$3.93 - $6.68 $507,363 - $862,388	129,100 New	129,100 $568,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $1.45M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.